Personalizing Brain Stimulation for Psychiatric Disorders: From Circuits to Closed-Loop Control.
Where this comes from
- Record sourced from PubMed, PMID 41764060.
- Also identified by DOI 10.1176/appi.ajp.20251327.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transcranial magnetic stimulation (TMS) is an established treatment for depression, yet response rates remain at 50% 1 month after treatment. Despite two decades of clinical use, substantial room for improvement remains. This overview examines biomarker-guided personalization of brain stimulation. The authors trace the translational path from invasive circuit-level insights through noninvasive biomarkers to clinical deployment. With validated biomarkers, systematic optimization becomes possible: stimulation parameter tuning, state-dependent approaches, augmentation strategies, and closed-loop systems. The path forward requires randomized trials demonstrating that biomarker-guided personalization improves outcomes beyond standard care, justifying increased complexity and costs. Success would mark an important pathway in interventional psychiatry's evolution to precision medicine.
Medical subject headings
- Transcranial Magnetic Stimulation
- Precision Medicine
- Mental Disorders
- Major Depressive Disorder